| abstract |
HBV replication inhibitors of Formula (IA) (see Formula) that include the stereochemically isomeric forms, as well as salts, hydrates and solvates thereof, where X and R1 to R6 have the meanings defined herein; The present invention also relates to processes for preparing said compounds, to pharmaceutical compositions containing them and to their use, alone or in combination with other HBV inhibitors, in the therapy against HBV. |